Page last updated: 2024-11-02

piracetam and Headache Disorders

piracetam has been researched along with Headache Disorders in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beran, RG1
Spira, PJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas[NCT04759196]Phase 456 participants (Anticipated)Interventional2021-03-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for piracetam and Headache Disorders

ArticleYear
Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).
    Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:5

    Topics: Adolescent; Adult; Aged; Analgesics; Australia; Cross-Over Studies; Double-Blind Method; Headache Di

2011